Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2012-04-03

Clinical Trial Update: Efficacy of Aliskiren Compared to Ramipril in the Treatment of Moderate Systolic Hypertensive Patients [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial compares the efficacy of aliskiren with ramipril in adults with essential hypertension; results were posted in 2012.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ramipril (ramipril)
  • Tekturna (aliskiren)

Snippet

Sponsor: Novartis | Conditions: Essential Hypertension | Phase 4 | Status: COMPLETED | Results posted: 2012-04-03